Lixte Biotechnology to Showcase Its Anti-Cancer Therapy Enhancer LB-100 at the Virtual 33rd Annual ROTH Capital Conference
March 03, 2021 09:35 ET
|
Lixte Biotechnology Holdings, Inc.
LB-100 is Currently in Clinical Studies for Four Cancer Targets: Phase 1b/2 for Myelodysplastic (MDS) SyndromesPhase 1b/2 for Advanced Soft Tissue SarcomaPhase 0 (Pharmacodynamics) for Glioblastoma...
MamaMancini’s to Attend 33rd Annual ROTH Conference
March 03, 2021 08:31 ET
|
MamaMancini's Holdings, Inc.
EAST RUTHERFORD, NJ, March 03, 2021 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (OTCQB: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, today announced that...
ME2C® Environmental to Attend Virtual 33rd Annual ROTH Conference
March 02, 2021 08:31 ET
|
Midwest Energy Emissions Corp.
CORSICANA, TX, March 02, 2021 (GLOBE NEWSWIRE) -- Midwest Energy Emissions Corp. (OTCQB: MEEC) ("ME2C Environmental" or the “Company”), a leading environmental technologies firm, today announced...